Related Experiment Videos
Scientific basis for an occupational standard for cadmium
M J Thun1, C G Elinder, L Friberg
1Department of Epidemiology and Statistics, American Cancer Society, Atlanta, GA 30329.
American Journal of Industrial Medicine
|January 1, 1991
Summary
The U.S. Occupational Safety and Health Administration (OSHA) proposed new limits for cadmium exposure. Evidence suggests the permissible exposure limit (PEL) should not exceed 5 micrograms/m3 to prevent lung cancer and kidney dysfunction.
Area of Science:
- Environmental Health
- Occupational Medicine
- Toxicology
Background:
- The U.S. Occupational Safety and Health Administration (OSHA) proposed revised 8-hour permissible exposure limits (PELs) for cadmium.
- These proposed limits are 1 or 5 micrograms/m3, aiming to prevent lung cancer and kidney dysfunction.
Purpose of the Study:
- To evaluate the scientific basis for OSHA's proposed cadmium exposure limits.
- To compare OSHA's risk estimates with empirical data from published literature.
Main Methods:
- Review of at least seven epidemiologic studies on renal tubular proteinuria and cumulative cadmium exposure.
- Analysis of qualitative and quantitative evidence for lung cancer carcinogenicity in human occupational cohorts.
- Comparison of risk estimates derived from mathematical modeling versus empirical data.
Main Results:
- Some studies indicate increased proteinuria at cumulative exposures below 500 micrograms/m3-year (equivalent to a PEL of 11.1 micrograms/m3).
- One study showed increased proteinuria between 100 and 299 micrograms/m3 (equivalent to a PEL of 2.2-6.6 micrograms/m3).
- Qualitative evidence suggests cadmium is a human carcinogen; quantitative risk estimates from human data are more plausible than rodent bioassay data.
Conclusions:
- Insufficient data exist to establish a no-effect level for cadmium-induced kidney toxicity.
- The permissible exposure limit (PEL) for cadmium should not exceed 5 micrograms/m3.
- This limit is recommended to protect workers from kidney dysfunction and lung cancer over a working lifetime.